Reuters logo
BRIEF-BioScrip can now dispense & administer radicava treatment option for amyotrophic lateral sclerosis
October 5, 2017 / 1:05 PM / in 17 days

BRIEF-BioScrip can now dispense & administer radicava treatment option for amyotrophic lateral sclerosis

Oct 5 (Reuters) - Bioscrip Inc

* BioScrip says can now dispense & administer Radicava (edaravone) treatment option for amyotrophic lateral sclerosis approved by U.S. FDA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below